The global ultrasonic tissue ablation system market is expected to reach USD 1,449.2 million by 2023 from USD 840.9 million in 2018, growing at a CAGR of 11.5%. Increasing prevalence of chronic diseases; rising adoption of minimally invasive surgeries; ongoing technological advancements in the field of ablation devices, growing awareness about benefits of ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
North America dominates the suture anchor devices market with the North America accounted major market share in 2017. Established healthcare infrastructure; and increasing demand for minimally invasive surgies are some of the major driving factors driving the growth of this market in North America. The Asian suture anchor devices market is poised to grow at the highest CAGR during the forecast period owing to improving healthcare infrastructure and rising awareness about advanced medical devices among people in the region. The rising focus of prominent players on the Asian ultrasonic tissue ablation systems market is another factor driving its growth. Furthermore, emerging countries such as India and China provides immense growth opportunities to the ultrasonic tissue ablation systems manufacturers.
Prominent players in the suture anchor devices market are Integra LifeSciences Corporation (US), Ethicon, Inc. (US), Misonix Inc. (US), Insightec ltd. (Japan), Alpinion Medical Systems Co., Ltd (US), Chongqing Haifu Medical Technology Co., Ltd.(China), Shanghai A&S Science Technology Development Co.,Ltd (China), Mianyang Sonic Electronic (Japan), and Theraclion (France).
This research report covers the global ultrasonic tissue ablation system market by method; product type; application; end user; and geography.
Table of Contents
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Crackdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data Points Taken From Secondary Sources
2.3.2 Key Data Points Taken From Primary Sources
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
6 Ultrasonic Tissue Ablation System Market, By Type
6.2 High-Intensity Focused Ultrasonic (Hifu) Ablators
6.3 Magnetic Resonance-Guided Focused Ultrasonic (Mrgfus) Ablators
6.4 Ultrasonic Surgical Ablation Systems
6.5 Shock Wave Therapy Systems
7 Ultrasonic Tissue Ablation System Market, By Application
7.2 Cardiac Disease
7.4 Pain Management
9 Ultrasonic Tissue Ablation System Market, By End User
9.3 Ambulatory Surgical Centers
9.3 Speciality Centers
9.4 Other End Users
10 Ultrasonic Tissue Ablation System Market, By Region
10.2 North America
10.3.6 Rest of Europe (RoE)
10.4 Asia Pacific
10.4.4 Rest of Asia Pacific
10.5 Rest of the World (RoW)
11 Competitive Landscape
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
12 Company Profiles*
12.2 Integra Lifesciences Corporation
12.3 Ethicon, Inc.
12.4 Misonix Inc.
12.5 Insightec Ltd.
12.6 Alpinion Medical Systems Co., Ltd.
12.7 Chongqing Haifu Medical Technology Co., Ltd.
12.8 Shanghai A&S Science Technology Development Co.,Ltd
12.9 Mianyang Sonic Electronic
Note: *Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
* 10 to 15 Market Leaders Will Be Profiled
* Segmentation May Change During the Planned Research Work
Benchmarking the rapid strategy shifts of the Top 100 companies in the Ultrasonic Tissue Ablation System MarketRequest For Special Pricing